Medically reviewed by Fedorchenko Olga Valeryevna, PharmD. Last updated on 26.06.2023

Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!

Effects on ability to drive and use machines

None known.

Undesirable effects

Nausea, skin rashes and joint pains have been reported in a few cases.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard

Overdose

As Nalcrom is only absorbed to a minimum extent, no action other than medical supervision should be necessary.

Pharmacodynamic properties

Pharmacotherapeutic group: Antiallergic agents, excluding corticosteroids, ATC Code: A07EB01

Sodium cromoglicate inhibits the release from mast cells of mediators of the allergic reaction. In gastrointestinal allergy the release of mediators can result in gastrointestinal symptoms or may allow absorption of antigenic material leading to systemic allergic reactions.

Pharmacokinetic properties

Not applicable

Pharmacotherapeutic group

Antiallergic agents, excluding corticosteroids, ATC Code: A07EB01

List of excipients

Purified Water

No 2 hard gelatin capsules

Black ink containing:

Water

Ethyl alcohol

Iso-propyl alcohol

Propylene alcohol